Kirk K Calhoun's Net Worth
$230 Thousand
Who is Kirk K Calhoun?
Kirk K Calhoun does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AMERICAN PHARMACEUTICAL PARTNERS INC /DE/, Abraxis Biosciences, Inc., Adams Respiratory Therapeutics, Inc., Ryerson Holding Corp, REPLIDYNE INC, PLx Pharma Inc., NantHealth, Inc., RESPONSE GENETICS INC, and MYOGEN INC.
SEC CIK
Kirk K Calhoun's CIK is 0001203721
Past Insider Trading and Trends
2007 was Kirk K Calhoun's most active year for acquiring shares with 13 total transactions. Kirk K Calhoun's most active month to acquire stocks was the month of October. 2010 was Kirk K Calhoun's most active year for disposing of shares, totalling 8 transactions. Kirk K Calhoun's most active month to dispose stocks was the month of September. 2006 saw Kirk K Calhoun paying a total of $200,700.00 for 25,273 shares, this is the most they've acquired in one year. In 2010 Kirk K Calhoun cashed out on 36,439 shares for a total of $919,296.63, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMERICAN PHARMACEUTICAL PARTNERS INC /DE/ No price found
InvestorKirk K Calhoun owns 10,000 units of Nonqualified Stock Option (Right to Purchase).acquired a total of 10,000 shares in AMERICAN PHARMACEUTICAL PARTNERS INC /DE/ at a cost of $200,700.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 10K |
$20.07 | $200,700.00 | 10K |
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 13
| |||
| No matching records found | |||||||||
Abraxis Biosciences, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adams Respiratory Therapeutics, Inc. No price found
InvestorKirk K Calhoun used to own units in Common Stock but no longer holds any shares there.acquired a total of 3,184 shares in Adams Respiratory Therapeutics, Inc., Kirk also disposed a total of 3,184 shares of Adams Respiratory Therapeutics, Inc. equalling to $191,040.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -3.18K |
$60.00 | -$191,040.00 |
0
|
Jan 29
| |||
Form 4
| +7.06% | 210 |
—
|
—
| 3.18K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 14
| |||
Form 4
| +12.18% | 323 |
—
|
—
| 2.97K |
Oct 1
| |||
Form 4
| +13.53% | 316 |
—
|
—
| 2.65K |
Jul 2
| |||
Form 4
| +19.07% | 374 |
—
|
—
| 2.33K |
Apr 2
| |||
Form 4
| +18.06% | 300 |
—
|
—
| 1.96K |
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 15
| |||
Form 4
| +27.28% | 356 |
—
|
—
| 1.66K |
Oct 2
| |||
Form 4
| +29.08% | 294 |
—
|
—
| 1.3K |
Jul 13
| |||
Form 4
| +45.26% | 315 |
—
|
—
| 1.01K |
Apr 1
| |||
Form 4
| +79.38% | 308 |
—
|
—
| 696 |
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 16
| |||
Form 4
|
∞
| 388 |
—
|
—
| 388 |
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ryerson Holding Corp (RYI) Snapshot price: $18.14
InvestorKirk K Calhoun owns 500 units of Common Stock, par value $0.01 per share which is worth $9,070.00, 1,313 units of Common Stock (par value ($0.01 per share) which is worth $23,817.82 and 1,761 units of Common Stock (par value $0.01 per share) which is worth $31,944.54. From 2014 to 2024 Kirk K Calhoun acquired a total of 1,761 shares in Ryerson Holding Corp at a cost of $5,500.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.12% | 448 |
—
|
—
| 1.76K |
Jul 1
| |||
Form 4
| +24.81% | 261 |
—
|
—
| 1.31K |
Apr 1
| |||
Form 4
| +31.50% | 252 |
—
|
—
| 1.05K |
Jan 12
| |||
Form 4
| +60.00% | 300 |
—
|
—
| 800 |
Oct 2
| |||
Form 4
|
∞
| 500 |
$11.00 | $5,500.00 | 500 |
Aug 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
REPLIDYNE INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||